Identifying the sequences that direct the spatial and temporal expression of genes and defining their function in vivo remains a significant challenge in the annotation of vertebrate genomes. One major obstacle is the lack of experimentally validated training sets. In this study, we made use of extreme evolutionary sequence conservation as a filter to identify putative gene regulatory elements, and characterized the in vivo enhancer activity of a large group of non-coding elements in the human genome that are conserved in human-pufferfish, Takifugu (Fugu) rubripes, or ultraconserved 1 in human-mouse-rat. We tested 167 of these extremely conserved sequences in a transgenic mouse enhancer assay. Here we report that 45% of these sequences functioned reproducibly as tissue-specific enhancers of gene expression at embryonic day 11.5. While directing expression in a broad range of anatomical structures in the embryo, the majority of the 75 enhancers directed expression to various regions of the developing nervous system. We identified sequence signatures enriched in a subset of these elements that targeted forebrain expression, and used these features to rank all 3,100 non-coding elements in the human genome that are conserved between human and Fugu. The testing of the top predictions in transgenic mice resulted in a threefold enrichment for sequences with forebrain enhancer activity. These data dramatically expand the catalogue of human gene enhancers that have been characterized in vivo, and illustrate the utility of such training sets for a variety of biological applications, including decoding the regulatory vocabulary of the human genome.
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Significant progress has been made in the identification of core promoter elements based on their defined position immediately upstream of each gene and their nearly universal activation by RNA polymerase II 2, 3 . However, the identification of distant acting gene regulatory sequences that direct precise spatial and temporal patterns of expression has been limited, despite their established roles in development 4 , phenotypic diversity 5 and human disease [6] [7] [8] . Comparative genomic-based approaches have proved to be useful in identifying gene regulatory sequences, primarily on a gene-bygene basis. These studies involved sequence comparisons of human (or other vertebrate) genomic intervals to orthologous regions from organisms separated by varying evolutionary distances, ranging from primates to fish [9] [10] [11] [12] . From this work it has been implied that ancient conservation (such as between human and fish) as well as 'ultra'-conservation among mammals (sequences at least 200 base pairs (bp) in length that are 100% identical among human/mouse/rat) 1 may be useful indicators of sequences with an increased likelihood of demonstrating gene regulatory activity. These gene-centric investigations, however, have identified only a relatively small number of distantacting enhancer sequences.
As one of the goals of this work was to assess the validity of a genome-based approach, rather than a gene-centric one, we chose non-coding target sequences based on one of two 'extreme' comparative genomic criteria: ancient conservation between human and Fugu (separated by ,450 million years of evolution) or ultraconservation among human/mouse/rat 1 . In total, 167 human DNA fragments were assessed for spatial enhancer activity in a wellestablished transgenic mouse enhancer assay that links the human conserved fragment to a minimal mouse heat shock promoter fused to a lacZ reporter gene 10, [13] [14] [15] [16] . We chose to determine tissue-specific reporter gene expression at embryonic day 11.5 (e11.5), as this developmental stage allows for whole-mount staining and whole-embryo visualization. Moreover, at this time-point many of the major tissues and organs have been specified. We also expected this stage to be particularly informative because 'extreme' conserved non-coding elements tend to be enriched and clustered near genes expressed during embryonic development 1, 12, 17, 18 . Overall, we found that 29% (24/83) of human-Fugu elements alone and 61% (33/54) of human-Fugu elements that are also ultraconserved were positive enhancers in this in vivo assay 1 
H u m a n -F u g u H u m a n -F u g u -u lt r a H u m a n -u lt r a Table 1 ; the entire data set including the sequence coordinates, conservation, and whole-mount embryo digital imagery can be accessed and queried at the VISTA Enhancer Browser, http://enhancer.lbl.gov). As an example of these data, we present 23 elements meeting our selection criteria that were located in a gene-poor 2.5 Mb stretch bracketing SALL1, a gene encoding a transcription factor expressed in early development and mutated in Townes-Brocks syndrome 19 ( Fig. 2) . Seven of the elements flanking SALL1 directed tissue-specific reporter gene expression in the transgenic in vivo assay, recapitulating aspects of SALL1's endogenous expression characteristics at e11.5 20 and further supporting the postulated modular nature of distant acting gene enhancers 21, 22 . In addition, we tested 30 ultraconserved non-coding sequences that lacked identifiable conservation with Fugu of which 18 (60%) functioned as enhancers, similar to the success rate observed for ultraconserved elements that also have Fugu conservation (Fig. 1) . Whereas the average size of the human fragments tested was 1,270 bp, the positive enhancers overlapped longer human-rodent conserved regions (average length 1,630 bp versus 966 bp; t-test P-value50.0087; see Supplementary Methods) and were more conserved among mammals (human-rodent conservation score, t-test P-value50.0004; see Supplementary Methods) relative to negatives in the assay.
These experimental results reveal the high propensity of extremely conserved human non-coding sequences to behave as transcriptional enhancers in vivo, and support both ancient human-fish conservation and human-rodent ultraconservation as highly effective filters to identify such functional elements. The large percentage of elements positive for enhancer activity is particularly surprising, considering the single time-point of investigation and the likely possibility that a fraction of the negatives may be enhancers active either earlier or later in development. An important question arising from the significant fraction of ultra and Fugu conserved elements functioning as enhancers is whether the tissue-specific enhancer activity that we assess completely explains why these sequences are so constrained. Overlaying our data set with results from a recent ChIP-Chip study 23 indicates that at least seven of the elements reported here (including four that are enhancers at e11.5) presumably function as gene silencers in embryonic stem cells. Such data imply that functions in addition to tissue-specific transcriptional activation are embedded in some fraction of extremely conserved non-coding elements, thus potentially contributing to their extreme level of constraint. However, the high efficiency of enhancer identification through this approach nonetheless suggests that tissue-specific transcriptional enhancer activity may be one of the predominant functions of non-coding genomic regions under extreme constraint throughout vertebrate evolution.
We categorized all 75 identified enhancers by their general anatomical patterns of expression using an existing standardized nomenclature 24 (Fig. 3) . All positive enhancer annotations are based on a minimum of three independent transgenic F 0 embryos carrying the same construct and demonstrating the same expression pattern, though the majority (83%) had four or more supporting embryos. We observed reporter gene expression in a variety of anatomical regions, including embryonic structures that are subject to major morphogenetic and remodelling events at e11.5, such as the developing limb, the somites, the heart and the branchial arches (Fig. 3) . Of the 16 distinct anatomical structures where expression was noted, it was most frequently observed in the central and peripheral nervous system, with the most prevalent patterns corresponding to forebrain, midbrain, neural tube, and hindbrain (Fig. 3) . This bias may be partially explained by the intrinsic complexity of the genetic cascades underlying vertebrate nervous system development 25 as well as the high percentage of all genes that are expressed in the nervous system.
The majority of the enhancers (50 elements, 66%) directed reproducible expression only to a single anatomical structure at the resolution of whole-mounts. This is consistent with the notion that complex endogenous messenger RNA expression patterns commonly result from the combined effects of several independent cisregulatory sequences. The remaining one-third (25/75) of the enhancers directed expression to two or more anatomical structures. We speculate that these enhancer elements may be composed of two or more adjacent functional modules that are too tightly linked to each other to be resolved by our comparative approach, or that several tissue-specific enhancer activities overlap within a single enhancer element that is used in more than one developmental process. Importantly, the enhancer data set reported here provides a sizeable sequence-based substrate to begin to dissect these possible regulatory mechanisms, as well as reagents for further in-depth biological investigation.
To explore if our in vivo enhancer data set could be used to identify sequence features associated with elements driving reporter gene expression in specific anatomical structures, we focused on the forebrain as a test case and selected as a training set four of the strongest enhancers identified early on in our survey. Using a motif finding strategy, we identified six motifs significantly over-represented in these enhancers (see Supplementary Methods). We then scored and ranked all ,3,100 human-Fugu conserved non-coding elements in the human genome (Supplementary Table 2) for the statistical overrepresentation of these putative forebrain motifs (Supplementary Methods). The 30 highest-ranking elements included the four known forebrain enhancers that constituted the training set as well as 26 additional elements (Supplementary Table 3 ). Of these 26 elements, 23 were successfully cloned and tested for in vivo enhancer activity in transgenic mice. We observed robust forebrain enhancer activity for 4 of the 23 elements (17%) tested in the transgenic assay system. By comparison, only 4 (5%) of the 77 otherwise uncharacterized human-Fugu conserved elements used to identify the training set were forebrain enhancers (see Supplementary Methods; Fig. 4 ). This preliminary result, although based on a small training set, indicates that a combined comparative and motif-based strategy provided a greater than threefold enrichment (P 5 0.08, see Supplementary Methods) over comparative-only approaches for the identification of enhancers active in a particular tissue of interest. This initial computational investigation also highlights the need for larger characterized enhancer training sets, the annotation of tissue specificities at high spatial resolution and the development of improved computational methods, which will probably provide a substrate to conclusively establish the predictive power of such approaches.
This study provides quantitative support for previous anecdotal observations that 'extreme' evolutionary non-coding conservation is a powerful predictor of mammalian tissue-specific enhancers. Of note, there are at least an additional 5,500 human-fish conserved non-coding sequences in the human genome with similar levels of constraint that are strong candidates for acting as gene enhancers 11 . The efficiency of enhancer identification coupled with the relatively high throughput transgenic assay used here represents a feasible approach for the generation of a genome-wide experimentally validated enhancer data set. Such collections are expected to define functional candidate regions as medical sequencing efforts escalate, as well as provide a foundation for inferring the network of regulatory interactions among key developmental genes during vertebrate development, analogous to the well-developed efforts in non-vertebrate model systems 21, 22 . Regulatory insights derived from these analyses should also enable the creation of modules driving predetermined expression patterns for various biological applications, as well as contribute to an understanding of the vocabulary and grammar of DNA sequences dictating gene expression.
METHODS
Identification of conserved elements and transgenic enhancer assay. HumanFugu conserved non-coding elements with 70% identity, a score of match-mismatch $60, and lacking evidence of encoding a protein or being transcribed in mRNA were derived from whole-genome alignments (see Supplementary Methods). The coordinates of ultraconserved elements were retrieved from ref. 1 . Conserved elements were amplified from human genomic DNA by polymerase chain reaction (PCR), sequence-validated and transferred into an Hsp68-LacZ reporter vector. Generation of transgenic mice and embryo staining was done as previously described 26 in accordance with protocols approved by the Lawrence Berkeley National Laboratory. For each enhancer fragment, all transgenic embryos exhibiting LacZ-staining were scored and annotated independently by multiple curators. Motif identification and prediction of forebrain enhancers. To find sequence motifs that were associated with forebrain expression, we used a discrete, enumerative motif-finding approach 27 . We identified motifs enriched in the training set of forebrain enhancers relative to three sets of background sequences: (1) random sequences from chromosome 16 (ATTAA and GATTA, which we note are motifs present in previously characterized embryonic forebrain enhancers 28, 29 ), (2) a chromosome 16 set of human-Fugu conserved elements (TTNNAAA, CANNGGC and TANNTGA), and (3) a chromosome 16 set of human-Fugu sequences that displayed enhancer activity (TTNNTTT) (see Supplementary Methods for details). We then combined information from all the motifs for the prediction of new forebrain enhancers in the genome by scoring each of 3,124 human/mouse/Fugu non-coding alignments 18 for the number of conserved (found aligned in human/mouse/Fugu) matches to each of the 6 significant 5-mers (see Supplementary Methods for details of scoring procedure). The top 30 fragments are available in Supplementary Table 3 
